TG Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK, INC. | 02/07/2025 | 21.90 M | $659.15 M | -0.26% | 15.09% |
VANGUARD GROUP INC | 02/11/2025 | 15.60 M | $469.45 M | 1.36% | 10.75% |
STATE STREET CORP | 02/14/2025 | 9.20 M | $276.92 M | 1.16% | 6.34% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 3.19 M | $96.15 M | -0.37% | 2.20% |
PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 2.79 M | $84.10 M | -22.01% | 1.93% |
SOLEUS CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 2.68 M | $80.71 M | 5.79% | 1.85% |
OPALEYE MANAGEMENT INC. | 02/14/2025 | 2.26 M | $68.03 M | -0.88% | 1.56% |
MORGAN STANLEY | 02/14/2025 | 2.16 M | $65.15 M | 0.00% | 1.49% |
CLEARBRIDGE INVESTMENTS, LLC | 02/12/2025 | 1.84 M | $55.24 M | 100.00% | 1.26% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 1.80 M | $54.15 M | -11.44% | 1.24% |
1832 ASSET MANAGEMENT L.P. | 02/14/2025 | 1.66 M | $49.82 M | 100.00% | 1.14% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 1.57 M | $47.39 M | -38.42% | 1.09% |
NORTHERN TRUST CORP | 02/14/2025 | 1.53 M | $46.14 M | 8.55% | 1.06% |
HOOD RIVER CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.46 M | $43.81 M | -10.74% | 1.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 1.27 M | $38.35 M | 51.98% | 0.88% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 1.27 M | $38.21 M | 7.17% | 0.87% |
FMR LLC | 02/13/2025 | 1.03 M | $31.05 M | -12.90% | 0.71% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 997.80 K | $30.03 M | 1.94% | 0.69% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 980.00 K | $29.50 M | 100.00% | 0.68% |
INVESCO LTD. | 02/13/2025 | 929.74 K | $27.99 M | 1.20% | 0.64% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 923.49 K | $27.80 M | 10.49% | 0.64% |
PRINCIPAL FINANCIAL GROUP INC | 01/31/2025 | 830.18 K | $24.99 M | 7.51% | 0.57% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 827.11 K | $24.90 M | 37.30% | 0.57% |
GROUP ONE TRADING, L.P. | 02/14/2025 | 757.52 K | $22.80 M | 22.50% | 0.52% |
EVENTIDE ASSET MANAGEMENT, LLC | 02/14/2025 | 718.81 K | $21.64 M | 0.00% | 0.50% |
683 CAPITAL MANAGEMENT, LLC | 02/14/2025 | 697.00 K | $20.98 M | -38.59% | 0.48% |
UBS GROUP AG | 02/14/2025 | 647.10 K | $19.48 M | -2.83% | 0.45% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 606.21 K | $18.25 M | -42.96% | 0.42% |
CITADEL ADVISORS LLC | 02/14/2025 | 545.20 K | $16.41 M | 103.58% | 0.38% |
JANE STREET GROUP, LLC | 02/14/2025 | 528.20 K | $15.90 M | 173.25% | 0.36% |
CITADEL ADVISORS LLC | 02/14/2025 | 513.96 K | $15.47 M | 310.73% | 0.35% |
RAYMOND JAMES FINANCIAL INC | 04/23/2025 | 481.99 K | $14.51 M | 100.00% | 0.33% |
AMERIPRISE FINANCIAL INC | 02/14/2025 | 459.04 K | $13.80 M | -0.07% | 0.32% |
ENSIGN PEAK ADVISORS, INC | 02/14/2025 | 456.02 K | $13.73 M | 0.00% | 0.31% |
BRAUN STACEY ASSOCIATES INC | 01/31/2025 | 442.81 K | $13.33 M | 100.00% | 0.31% |
JANE STREET GROUP, LLC | 02/14/2025 | 439.20 K | $13.22 M | 40.05% | 0.30% |
NORGES BANK | 02/12/2025 | 401.50 K | $12.09 M | 100.00% | 0.28% |
LEGAL & GENERAL GROUP PLC | 02/13/2025 | 391.39 K | $11.78 M | 1.70% | 0.27% |
RHUMBLINE ADVISERS | 01/30/2025 | 383.11 K | $11.53 M | 0.13% | 0.26% |
JPMORGAN CHASE & CO | 02/12/2025 | 382.96 K | $11.53 M | -46.87% | 0.26% |
PENN CAPITAL MANAGEMENT COMPANY, LLC | 02/14/2025 | 351.41 K | $10.58 M | 100.00% | 0.24% |
CITIGROUP INC | 02/12/2025 | 347.18 K | $10.45 M | 106.31% | 0.24% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 02/14/2025 | 332.58 K | $10.01 M | 17.52% | 0.23% |
RAFFERTY ASSET MANAGEMENT, LLC | 02/14/2025 | 331.41 K | $9.98 M | -2.66% | 0.23% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 331.40 K | $9.98 M | 85.43% | 0.23% |
CITADEL ADVISORS LLC | 02/14/2025 | 324.90 K | $9.78 M | -0.55% | 0.22% |
BARCLAYS PLC | 02/13/2025 | 317.56 K | $9.56 M | -8.50% | 0.22% |
NEW YORK STATE COMMON RETIREMENT FUND | 01/31/2025 | 299.40 K | $9.01 M | 403.06% | 0.21% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 297.10 K | $8.94 M | 264.54% | 0.20% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 291.24 K | $8.77 M | 100.00% | 0.20% |
TG Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 343 institutional investors and hedge funds held shares of TG Therapeutics, Inc.. The most heavily invested institutionals were:
DiNuzzo Private Wealth, Inc.: 0
Bleakley Financial Group, LLC: 0
MISSION WEALTH MANAGEMENT, LP: 0
PSI Advisors, LLC: 0
Strategic Financial Concepts, LLC: 0
Precision Wealth Strategies, LLC: 0
66.76% of TG Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 88.95 M shares in the last 24 months. This purchase volume represents approximately $3.86 B in transactions.